Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder-Reference-Cited by-同舟云学术

Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder

Published:2018-05 Issue:5 Volume:20 Page:706-714
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Kalra Amit,Roessner Cameron^ORCID,Jupp Jennifer,Williamson Tyler,Tellier Raymond,Chaudhry Ahsan,Khan Faisal,Taparia Minakshi,Jimenez-Zepeda Victor H.,Stewart Douglas A.,Daly Andrew,Storek Jan

Funder

Alberta Innovates-Health Solutions

Alberta Cancer Foundation

Buckley Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference42 articles.

1. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study;Curtis;Blood,1999

2. Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab;Patriarca;Transpl Infect Dis,2013

3. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation;Brunstein;Blood,2006

4. Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation;Comoli;Am J Transplant,2007

5. C. Users, risks of developing epstein-barr virus–related lymphoproliferative disorders after T-Cell–Depleted marrow transplants;Hale;Blood,1998

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

2. A Multiplex Fluorescence of Loop Primer Upon Self-Dequenching Loop-Mediated Isothermal Amplification Assay for the Detection of Epstein–Barr Virus and Human Parvovirus B19 in Clinical Transplant Samples;Viral Immunology;2024-05-01

3. Epstein-Barr Virus: A Novel Dimension in Cancer Development;Pathogens Associated with the Development of Cancer in Humans;2024

4. Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?;Bone Marrow Transplantation;2023-11-25

5. Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes;International Journal of Molecular Sciences;2023-11-07